Leptin at the intersection of neuroendocrinology and metabolism: Current evidence and therapeutic perspectives

Cell Metabolism

Volumn 18, Issue 1, 2013, Pages 29-42

  Dalamaga, Maria ^a   Chou, Sharon H ^b   Shields, Kelsey ^b   Papageorgiou, Panagiotis ^b   Polyzos, Stergios A ^c   Mantzoros, Christos S ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; CHOLECYSTOKININ; ESTRADIOL; GLUCAGON LIKE PEPTIDE 1; GONADORELIN; INTERLEUKIN 12; INTERLEUKIN 6; JANUS KINASE 2; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 3; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA;

ARCUATE NUCLEUS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALORIC INTAKE; CARBOHYDRATE METABOLISM; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; COGNITION; CYTOKINE RELEASE; ELECTROENCEPHALOGRAM; ENDOPLASMIC RETICULUM STRESS; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; INTRACELLULAR SIGNALING; LEPTIN DEFICIENCY; LIPOTOXICITY; LOCOMOTION; LYMPHOCYTE PROLIFERATION; MESOLIMBIC DOPAMINERGIC SYSTEM; METABOLISM; MIDDLE FRONTAL GYRUS; MINERALIZATION; NATURAL KILLER CELL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINOLOGY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBESITY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS FAT; SYNAPTOGENESIS; TRANS GOLGI NETWORK; VENTRAL TEGMENTUM;

BONE AND BONES; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM; COGNITION; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; LEPTIN; NEUROSECRETORY SYSTEMS;

EID: 84879882621     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.05.010     Document Type: Review

References (98)

1. K.A. Anderson, T.J. Ribar, F. Lin, P.K. Noeldner, M.F. Green, M.J. Muehlbauer, L.A. Witters, B.E. Kemp, and A.R. Means Hypothalamic CaMKK2 contributes to the regulation of energy balance Cell Metab. 7 2008 377 388
2. V.P. Andreev, G. Paz-Filho, M.L. Wong, and J. Licinio Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment Horm. Metab. Res. 41 2009 142 151
3. K.N. Aronis, K.N. Diakopoulos, C.G. Fiorenza, J.P. Chamberland, and C.S. Mantzoros Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans Diabetologia 54 2011 2358 2367
4. K. Baicy, E.D. London, J. Monterosso, M.L. Wong, T. Delibasi, A. Sharma, and J. Licinio Leptin replacement alters brain response to food cues in genetically leptin-deficient adults Proc. Natl. Acad. Sci. USA 104 2007 18276 18279
5. P.A. Baldock, S. Allison, M.M. McDonald, A. Sainsbury, R.F. Enriquez, D.G. Little, J.A. Eisman, E.M. Gardiner, and H. Herzog Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways J. Bone Miner. Res. 21 2006 1600 1607
6. S.M. Bartell, S. Rayalam, S. Ambati, D.R. Gaddam, D.L. Hartzell, M. Hamrick, J.X. She, M.A. Della-Fera, and C.A. Baile Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice J. Bone Miner. Res. 26 2011 1710 1720
7. L. Bayer, C. Jacquemard, D. Fellmann, and B. Griffond Survival of rat MCH (melanin-concentrating hormone) neurons in hypothalamus slice culture: histological, pharmacological and molecular studies Cell Tissue Res. 297 1999 23 33
8. S. Blüher, and C.S. Mantzoros Leptin in humans: lessons from translational research Am. J. Clin. Nutr. 89 2009 991S 997S
9. G. Boden, X. Chen, M. Mozzoli, and I. Ryan Effect of fasting on serum leptin in normal human subjects J. Clin. Endocrinol. Metab. 81 1996 3419 3423
10. C.M. Boustany-Kari, V.M. Jackson, C.P. Gibbons, and A.G. Swick Leptin potentiates the anti-obesity effects of rimonabant Eur. J. Pharmacol. 658 2011 270 276
11. A.M. Brennan, and C.S. Mantzoros Drug Insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications Nat. Clin. Pract. Endocrinol. Metab. 2 2006 318 327
12. A.M. Brennan, J.H. Lee, S. Tsiodras, J.L. Chan, J. Doweiko, S.N. Chimienti, S.G. Wadhwa, A.W. Karchmer, and C.S. Mantzoros r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans Eur. J. Endocrinol. 160 2009 173 176
13. S.J. Brooks, C. Benedict, J. Burgos, M.J. Kempton, J. Kullberg, R. Nordenskjöld, L. Kilander, R. Nylander, E.M. Larsson, and L. Johansson Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study Int. J. Obes. (Lond.) 37 2013 230 236
14. F. Carbone, C. La Rocca, and G. Matarese Immunological functions of leptin and adiponectin Biochimie 94 2012 2082 2088
15. S. Carnell, C. Gibson, L. Benson, C.N. Ochner, and A. Geliebter Neuroimaging and obesity: current knowledge and future directions Obes. Rev. 13 2012 43 56
16. J.L. Chan, and C.S. Mantzoros Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa Lancet 366 2005 74 85
17. J.L. Chan, K. Heist, A.M. DePaoli, J.D. Veldhuis, and C.S. Mantzoros The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men J. Clin. Invest. 111 2003 1409 1421
18. J.L. Chan, J. Bullen, V. Stoyneva, A.M. Depaoli, C. Addy, and C.S. Mantzoros Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess J. Clin. Endocrinol. Metab. 90 2005 1618 1624
19. J.L. Chan, G. Matarese, G.K. Shetty, P. Raciti, I. Kelesidis, D. Aufiero, V. De Rosa, F. Perna, S. Fontana, and C.S. Mantzoros Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans Proc. Natl. Acad. Sci. USA 103 2006 8481 8486
20. J.L. Chan, J.E. Mietus, P.M. Raciti, A.L. Goldberger, and C.S. Mantzoros Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans Clin. Endocrinol. (Oxf.) 66 2007 49 57
21. S.H. Chou, J.P. Chamberland, X. Liu, G. Matarese, C. Gao, R. Stefanakis, M.T. Brinkoetter, H. Gong, K. Arampatzi, and C.S. Mantzoros Leptin is an effective treatment for hypothalamic amenorrhea Proc. Natl. Acad. Sci. USA 108 2011 6585 6590
22. M.A. Cowley, J.L. Smart, M. Rubinstein, M.G. Cerdán, S. Diano, T.L. Horvath, R.D. Cone, and M.J. Low Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus Nature 411 2001 480 484
23. T.A. Dardeno, S.H. Chou, H.S. Moon, J.P. Chamberland, C.G. Fiorenza, and C.S. Mantzoros Leptin in human physiology and therapeutics Front. Neuroendocrinol. 31 2010 377 393
24. I.S. Farooqi, G. Matarese, G.M. Lord, J.M. Keogh, E. Lawrence, C. Agwu, V. Sanna, S.A. Jebb, F. Perna, and S. Fontana Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J. Clin. Invest. 110 2002 1093 1103
25. I.S. Farooqi, E. Bullmore, J. Keogh, J. Gillard, S. O'Rahilly, and P.C. Fletcher Leptin regulates striatal regions and human eating behavior Science 317 2007 1355
26. S. Frank, M. Heni, A. Moss, J. von Schnurbein, A. Fritsche, H.U. Häring, S. Farooqi, H. Preissl, and M. Wabitsch Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas J. Clin. Endocrinol. Metab. 96 2011 E1283 E1287
27. J.E. Galgani, F.L. Greenway, S. Caglayan, M.L. Wong, J. Licinio, and E. Ravussin Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients J. Clin. Endocrinol. Metab. 95 2010 851 855
28. A.S. Garfield, C. Patterson, S. Skora, F.M. Gribble, F. Reimann, M.L. Evans, M.G. Myers Jr., and L.K. Heisler Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract Endocrinology 153 2012 4600 4607
29. S. Gazdzinski, J. Kornak, M.W. Weiner, and D.J. Meyerhoff Body mass index and magnetic resonance markers of brain integrity in adults Ann. Neurol. 63 2008 652 657
30. J.P. German, B.E. Wisse, J.P. Thaler, S. Oh-I, D.A. Sarruf, K. Ogimoto, K.J. Kaiyala, J.D. Fischer, M.E. Matsen, and G.J. Taborsky Jr. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes Diabetes 59 2010 1626 1634
31. J.P. German, J.P. Thaler, B.E. Wisse, S. Oh-I, D.A. Sarruf, M.E. Matsen, J.D. Fischer, G.J. Taborsky Jr., M.W. Schwartz, and G.J. Morton Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia Endocrinology 152 2011 394 404
32. W.T. Gibson, I.S. Farooqi, M. Moreau, A.M. DePaoli, E. Lawrence, S. O'Rahilly, and R.A. Trussell Congenital leptin deficiency due to homozygosity for the Δ133G mutation: report of another case and evaluation of response to four years of leptin therapy J. Clin. Endocrinol. Metab. 89 2004 4821 4826
33. J.O. Gordeladze, C.A. Drevon, U. Syversen, and J.E. Reseland Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling J. Cell. Biochem. 85 2002 825 836
34. M.W. Hamrick, and S.L. Ferrari Leptin and the sympathetic connection of fat to bone Osteoporos. Int. 19 2008 905 912
35. M.W. Hamrick, M.A. Della-Fera, Y.H. Choi, C. Pennington, D. Hartzell, and C.A. Baile Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice J. Bone Miner. Res. 20 2005 994 1001
36. S.B. Heymsfield, A.S. Greenberg, K. Fujioka, R.M. Dixon, R. Kushner, T. Hunt, J.A. Lubina, J. Patane, B. Self, P. Hunt, and M. McCamish Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA 282 1999 1568 1575
37. W.R. Holloway, F.M. Collier, C.J. Aitken, D.E. Myers, J.M. Hodge, M. Malakellis, T.J. Gough, G.R. Collier, and G.C. Nicholson Leptin inhibits osteoclast generation J. Bone Miner. Res. 17 2002 200 209
38. J.D. Hommel, R. Trinko, R.M. Sears, D. Georgescu, Z.W. Liu, X.B. Gao, J.J. Thurmon, M. Marinelli, and R.J. DiLeone Leptin receptor signaling in midbrain dopamine neurons regulates feeding Neuron 51 2006 801 810
39. J.K. Howard, G.M. Lord, G. Matarese, S. Vendetti, M.A. Ghatei, M.A. Ritter, R.I. Lechler, and S.R. Bloom Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice J. Clin. Invest. 104 1999 1051 1059
40. J.J. Hwang, J.L. Chan, G. Ntali, D. Malkova, and C.S. Mantzoros Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans Diabetes Care 31 2008 945 951
41. T. Kelesidis, I. Kelesidis, S. Chou, and C.S. Mantzoros Narrative review: the role of leptin in human physiology: emerging clinical applications Ann. Intern. Med. 152 2010 93 100
42. S.N. Khan, G. Duraine, S.S. Virk, J. Fung, D. Rowland, A.H. Reddi, and M.A. Lee The temporal role of leptin within fracture healing and the effect of local application of recombinant leptin on fracture healing J. Orthop. Trauma 2013 10.1097/BOT.0b013e3182847968 Published online January 2, 2013
43. Y.W. Kim, J.Y. Kim, Y.H. Park, S.Y. Park, K.C. Won, K.H. Choi, J.Y. Huh, and K.H. Moon Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance Diabetes 55 2006 716 724
44. K.W. Kim, J.W. Sohn, D. Kohno, Y. Xu, K. Williams, and J.K. Elmquist SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis Mol. Cell. Endocrinol. 336 2011 219 223
45. K.W. Kim, J. Donato Jr., E.D. Berglund, Y.H. Choi, D. Kohno, C.F. Elias, R.A. Depinho, and J.K. Elmquist FOXO1 in the ventromedial hypothalamus regulates energy balance J. Clin. Invest. 122 2012 2578 2589
46. H.R. Kissileff, J.C. Thornton, M.I. Torres, K. Pavlovich, L.S. Mayer, V. Kalari, R.L. Leibel, and M. Rosenbaum Leptin reverses declines in satiation in weight-reduced obese humans Am. J. Clin. Nutr. 95 2012 309 317
47. T. Kusakabe, H. Tanioka, K. Ebihara, M. Hirata, L. Miyamoto, F. Miyanaga, H. Hige, D. Aotani, T. Fujisawa, and H. Masuzaki Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet Diabetologia 52 2009 675 683
48. E.S. Leblanc, E. O'Connor, E.P. Whitlock, C.D. Patnode, and T. Kapka Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force Ann. Intern. Med. 155 2011 434 447
49. J.H. Lee, J.L. Chan, E. Sourlas, V. Raptopoulos, and C.S. Mantzoros Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy J. Clin. Endocrinol. Metab. 91 2006 2605 2611
50. Y.H. Lee, F. Magkos, C.S. Mantzoros, and E.S. Kang Effects of leptin and adiponectin on pancreatic β-cell function Metabolism 60 2011 1664 1672
51. G.M. Leinninger, Y.H. Jo, R.L. Leshan, G.W. Louis, H. Yang, J.G. Barrera, H. Wilson, D.M. Opland, M.A. Faouzi, and Y. Gong Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding Cell Metab. 10 2009 89 98
52. G.Y. Liao, J.J. An, K. Gharami, E.G. Waterhouse, F. Vanevski, K.R. Jones, and B. Xu Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin Nat. Med. 18 2012 564 571
53. J. Licinio, S. Caglayan, M. Ozata, B.O. Yildiz, P.B. de Miranda, F. O'Kirwan, R. Whitby, L. Liang, P. Cohen, and S. Bhasin Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults Proc. Natl. Acad. Sci. USA 101 2004 4531 4536
54. W. Lieb, A.S. Beiser, R.S. Vasan, Z.S. Tan, R. Au, T.B. Harris, R. Roubenoff, S. Auerbach, C. DeCarli, P.A. Wolf, and S. Seshadri Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging JAMA 302 2009 2565 2572
55. E.D. London, S.M. Berman, S. Chakrapani, T. Delibasi, J. Monterosso, H.K. Erol, G. Paz-Filho, M.L. Wong, and J. Licinio Short-term plasticity of gray matter associated with leptin deficiency and replacement J. Clin. Endocrinol. Metab. 96 2011 E1212 E1220
56. C.S. Mantzoros, M. Ozata, A.B. Negrao, M.A. Suchard, M. Ziotopoulou, S. Caglayan, R.M. Elashoff, R.J. Cogswell, P. Negro, and V. Liberty Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans J. Clin. Endocrinol. Metab. 86 2001 3284 3291
57. P. Maroni, P. Bendinelli, and R. Piccoletti Intracellular signal transduction pathways induced by leptin in C2C12 cells Cell Biol. Int. 29 2005 542 550
58. G. Marwarha, B. Dasari, J.R. Prasanthi, J. Schommer, and O. Ghribi Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices J. Alzheimers Dis. 19 2010 1007 1019
59. G. Matarese, C. La Rocca, H.-S. Moon, J.Y. Huh, M.T. Brinkoetter, S. Chou, F. Perna, D. Greco, H.P. Kilim, and C. Gao Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia Proc. Natl. Acad. Sci. USA 110 2013 E818 E827
60. J.A. Matochik, E.D. London, B.O. Yildiz, M. Ozata, S. Caglayan, A.M. DePaoli, M.L. Wong, and J. Licinio Effect of leptin replacement on brain structure in genetically leptin-deficient adults J. Clin. Endocrinol. Metab. 90 2005 2851 2854
61. K.K. Miller, M.S. Parulekar, E. Schoenfeld, E. Anderson, J. Hubbard, A. Klibanski, and S.K. Grinspoon Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake J. Clin. Endocrinol. Metab. 83 1998 2309 2312
62. Y. Minokoshi, Y.B. Kim, O.D. Peroni, L.G. Fryer, C. Müller, D. Carling, and B.B. Kahn Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339 343
63. B. Mittendorfer, J.F. Horowitz, A.M. DePaoli, M.A. McCamish, B.W. Patterson, and S. Klein Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes Diabetes 60 2011 1474 1477
64. H.S. Moon, G. Matarese, A.M. Brennan, J.P. Chamberland, X. Liu, C.G. Fiorenza, G.H. Mylvaganam, L. Abanni, F. Carbone, and C.J. Williams Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance Diabetes 60 2011 1647 1656
65. S.A. Moran, N. Patten, J.R. Young, E. Cochran, N. Sebring, J. Reynolds, A. Premkumar, A.M. Depaoli, M.C. Skarulis, E.A. Oral, and P. Gorden Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy Metabolism 53 2004 513 519
66. T.D. Müller, L.M. Sullivan, K. Habegger, C.X. Yi, D. Kabra, E. Grant, N. Ottaway, R. Krishna, J. Holland, and J. Hembree Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21 J. Pept. Sci. 18 2012 383 393
67. K. Mulligan, H. Khatami, J.M. Schwarz, G.K. Sakkas, A.M. DePaoli, V.W. Tai, M.J. Wen, G.A. Lee, C. Grunfeld, and M. Schambelan The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia J. Clin. Endocrinol. Metab. 94 2009 1137 1144
68. C. Musso, E. Cochran, E. Javor, J. Young, A.M. Depaoli, and P. Gorden The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients Metabolism 54 2005 255 263
69. M.G. Myers Jr., R.L. Leibel, R.J. Seeley, and M.W. Schwartz Obesity and leptin resistance: distinguishing cause from effect Trends Endocrinol. Metab. 21 2010 643 651
70. E.A. Oral, E.D. Javor, L. Ding, G. Uzel, E.K. Cochran, J.R. Young, A.M. DePaoli, S.M. Holland, and P. Gorden Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy J. Clin. Endocrinol. Metab. 91 2006 621 628
71. M. Ozata, I.C. Ozdemir, and J. Licinio Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects J. Clin. Endocrinol. Metab. 84 1999 3686 3695
72. N. Pannacciulli, A. Del Parigi, K. Chen, D.S. Le, E.M. Reiman, and P.A. Tataranni Brain abnormalities in human obesity: a voxel-based morphometric study Neuroimage 31 2006 1419 1425
73. N. Pannacciulli, D.S. Le, K. Chen, E.M. Reiman, and J. Krakoff Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study Neurosci. Lett. 412 2007 248 253
74. E. Papathanassoglou, K. El-Haschimi, X.C. Li, G. Matarese, T. Strom, and C. Mantzoros Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice J. Immunol. 176 2006 7745 7752
75. V.C. Pardini, I.M. Victória, S.M. Rocha, D.G. Andrade, A.M. Rocha, F.B. Pieroni, G. Milagres, S. Purisch, and G. Velho Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes J. Clin. Endocrinol. Metab. 83 1998 503 508
76. J.Y. Park, A.Y. Chong, E.K. Cochran, D.E. Kleiner, M.J. Haller, D.A. Schatz, and P. Gorden Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy J. Clin. Endocrinol. Metab. 93 2008 26 31
77. G.J. Paz-Filho, A. Ayala, K. Esposito, H.K. Erol, T. Delibasi, B.E. Hurwitz, M.L. Wong, and J. Licinio Effects of leptin on lipid metabolism Horm. Metab. Res. 40 2008 572 574
78. G.J. Paz-Filho, T. Babikian, R. Asarnow, T. Delibasi, K. Esposito, H.K. Erol, M.L. Wong, and J. Licinio Leptin replacement improves cognitive development PLoS ONE 3 2008 e3098
79. K.F. Petersen, E.A. Oral, S. Dufour, D. Befroy, C. Ariyan, C. Yu, G.W. Cline, A.M. DePaoli, S.I. Taylor, P. Gorden, and G.I. Shulman Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy J. Clin. Invest. 109 2002 1345 1350
80. S.A. Polyzos, J. Kountouras, C. Zavos, and G. Deretzi The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature J. Clin. Gastroenterol. 45 2011 50 54
81. E. Ravussin, S.R. Smith, J.A. Mitchell, R. Shringarpure, K. Shan, H. Maier, J.E. Koda, and C. Weyer Enhanced weight loss with pramlintide/ metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy Obesity (Silver Spring) 17 2009 1736 1743
82. J.N. Roemmich, P.A. Clark, C.S. Mantzoros, C.M. Gurgol, A. Weltman, and A.D. Rogol Relationship of leptin to bone mineralization in children and adolescents J. Clin. Endocrinol. Metab. 88 2003 599 604
83. M. Rosenbaum, and R.L. Leibel Clinical review 107: Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin J. Clin. Endocrinol. Metab. 84 1999 1784 1789
84. M. Rosenbaum, R. Goldsmith, D. Bloomfield, A. Magnano, L. Weimer, S. Heymsfield, D. Gallagher, L. Mayer, E. Murphy, and R.L. Leibel Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight J. Clin. Invest. 115 2005 3579 3586
85. M. Rosenbaum, M. Sy, K. Pavlovich, R.L. Leibel, and J. Hirsch Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli J. Clin. Invest. 118 2008 2583 2591
86. J.D. Roth, B.L. Roland, R.L. Cole, J.L. Trevaskis, C. Weyer, J.E. Koda, C.M. Anderson, D.G. Parkes, and A.D. Baron Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies Proc. Natl. Acad. Sci. USA 105 2008 7257 7262
87. Y. Sato, M. Nagasaki, M. Kubota, T. Uno, and N. Nakai Clinical aspects of physical exercise for diabetes/metabolic syndrome Diabetes Res. Clin. Pract. 77 Suppl 1 2007 S87 S91
88. P.J. Scarpace, M. Matheny, B.H. Pollock, and N. Tümer Leptin increases uncoupling protein expression and energy expenditure Am. J. Physiol. 273 1997 E226 E230
89. G. Segal-Lieberman, R.L. Bradley, E. Kokkotou, M. Carlson, D.J. Trombly, X. Wang, S. Bates, M.G. Myers Jr., J.S. Flier, and E. Maratos-Flier Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype Proc. Natl. Acad. Sci. USA 100 2003 10085 10090
90. R.V. Sekhar, F. Jahoor, D. Iyer, A. Guthikonda, J. Paranilam, F. Elhaj, I. Coraza, and A. Balasubramanyam Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome Metabolism 61 2012 1395 1403
91. G.K. Shetty, G. Matarese, F. Magkos, H.S. Moon, X. Liu, A.M. Brennan, G. Mylvaganam, D. Sykoutri, A.M. Depaoli, and C.S. Mantzoros Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet Eur. J. Endocrinol. 165 2011 249 254
92. E. Sienkiewicz, F. Magkos, K.N. Aronis, M. Brinkoetter, J.P. Chamberland, S. Chou, K.M. Arampatzi, C. Gao, A. Koniaris, and C.S. Mantzoros Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women Metabolism 60 2011 1211 1221
93. F.R. Smink, D. van Hoeken, and H.W. Hoek Epidemiology of eating disorders: incidence, prevalence and mortality rates Curr. Psychiatry Rep. 14 2012 406 414
94. P. Sumithran, L.A. Prendergast, E. Delbridge, K. Purcell, A. Shulkes, A. Kriketos, and J. Proietto Long-term persistence of hormonal adaptations to weight loss N. Engl. J. Med. 365 2011 1597 1604
95. L. Vong, C. Ye, Z. Yang, B. Choi, S. Chua Jr., and B.B. Lowell Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons Neuron 71 2011 142 154
96. M.Y. Wang, L. Chen, G.O. Clark, Y. Lee, R.D. Stevens, O.R. Ilkayeva, B.R. Wenner, J.R. Bain, M.J. Charron, C.B. Newgard, and R.H. Unger Leptin therapy in insulin-deficient type I diabetes Proc. Natl. Acad. Sci. USA 107 2010 4813 4819
97. C.K. Welt, J.L. Chan, J. Bullen, R. Murphy, P. Smith, A.M. DePaoli, A. Karalis, and C.S. Mantzoros Recombinant human leptin in women with hypothalamic amenorrhea N. Engl. J. Med. 351 2004 987 997
98. A. Yamanaka, C.T. Beuckmann, J.T. Willie, J. Hara, N. Tsujino, M. Mieda, M. Tominaga, Ki. Yagami, F. Sugiyama, and K. Goto Hypothalamic orexin neurons regulate arousal according to energy balance in mice Neuron 38 2003 701 713 Diseases Diseases Diseases Diseases